Abstract:B76 Measurements of parameters such as apparent diffusion coefficient (ADC) of water and tissue Na + by magnetic resonance (MR) techniques have been suggested as noninvasive methods for predicting and/or monitoring response to therapy (1, 2). We and others have found that effective chemotherapy of subcutaneously (sc) implanted Radiation Induced Fibrosarcome (RIF-1) in mice with cyclophosphamide (1) and 5-fluorouracil (3), as well as, chemotherapy of intracranial 9L glioma in rats with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) (1) correlate with increases in both total tumor tissue 23 Na signal intensity (SI) and water ADC in the first 3-5 post-treatment days. The most frequently cited hypothesis explaining an increase in tumor water ADC and 23 Na SI following therapy is that tumor cell death by apoptosis or necrosis invoke a net increase in extracellular space (ECS), an environment of assumed fast-diffusing water and high [Na + ] (1, 4). However, this clarification does not explain our results of BCNU treatment of sc-implanted 9L glioma. We have found that in sc-implanted 9L glioma 23 Na SI and water ADC significantly increase with growth in untreated control and non-responsive glioma, while in BCNU-responsive glioma both 23 Na SI and water ADC were almost unchanged (5). It appears the increase in water ADC and 23 Na SI after chemotherapy is not general phenomena resulting from an increase in ECS. Furthermore, in sc-implanted 9L glioma, Winter et al. (6) did not find any changes in the relative ECS, explaining the lower [Na + ] t in BCNU-treated tumors by improvement of tumor oxygenation and perfusion. We hypothesized that the different results in sc-implanted and intracranial glioma could be caused by location of tumors. However, Schepkin et al. recently reported the increase in water ADC and 23 Na SI in sc-implanted 9L glioma treated by BNCU (7). We assumed that the source of cell culture can play a role in different effects of BCNU. In our study, we used 9L cells from American Type Culture Collection (ATCC), while others (1, 7) used 9L cells from Brain Tumor Research Center, UCSF. Our preliminary results show a one week delay in the sc-growth of 9L glioma from ATCC compared to the tumor growth initiated by cells from UCSF. Additional estimation should be done to evaluate the possible role of type of anesthesia and tumor size in efficiency of BCNU treatment in experimental 9L glioma.References: (1) Schepkin et al. MRM, 53: 85-92, 2005; (2) Babsky et al. Neoplasia, 7: 658-66, 2005; (3) Babsky et al. ISMRM, p.1767, 2006; (4) Ross et al. Eur J Cancer, 38: 2147-56, 2002; (5) Babsky et al. JMRI, 24: 132-9, 2006; (6) Winter et al. Cancer Res 61: 2002-7, 2001; (7) Schepkin et al. MRI, 24: 273-8, 2006.

[Effects of Various Antitumor Agents on Intracerebrally Inoculated Ehrlich Ascites Carcinoma in Mice (author's Transl)].

Enhanced Antitumor Activity of SarCNU in Comparison to BCNU in an Extraneuronal Monoamine Transporter Positive Human Glioma Xenograft Model

The Superparamagnetic Nanoparticles Carrying the E1A Gene Enhance the Radiosensitivity of Human Cervical Carcinoma in Nude Mice

The Problems of Monitoring Response to Chemotherapy in Subcutaneously Implanted 9L Glioma Using Apparent Diffusion Coefficient of Water and 23na Magnetic Resonance Imaging

STUDIES ON ANTITUMOR DRUGS X. THE EFFECT OF ACTINOMYCIN K ON MITOSIS OF EHRLICH ASCITES CARCINOMA CELLS

Therapeutic effect of SarCNU in the treatment of human glioma nude mice model

Effect and Feasibility in Treating Tmnor-bearing Mice with ~(125) I Seeds Carrier Sheet

Anti-tumor Activity of Brucine on Mice with Transplanted Tumor

Effects of Different Number of Tumor Cells on Xenograft Tumor Growth and Efficacy of Anti-Tumor Agents in Mice

The Effect of the Cxcr7 Inhibitor Ccx662 on Survival in the Enu Rat Model of Glioblastoma

Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [131I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice

Combined Use of Insoluble Beta-Glucan from the Cell Wall of Candida Albicans and Cyclophosphamide: Validation in S180 Tumor-Bearing Mice

Antitumor Efficacy of SarCNU in a Human Glioma Xenograft Model Expressing Both MGMT and Extraneuronal Monoamine Transporter

Enhanced Tumor Inhibiting Effect of 131I-Bdi-1-based Radioimmunotherapy and Cytosine Deaminase Gene Therapy Modulated by a Radio-Sensitive Promoter in Nude Mice Bearing Bladder Cancer

Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice

Antitumor effect of nitidine chloride in vitro and in vivo

Evaluation of the antitumor activity of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol (chlonisol) in C57BL/6 mice with intracranially transplanted B16 melanoma

[Anti-Tumor Efficacy of 2-Chloroethyl-3-sarcosinamide-1-nitrosourea in a Human Lung Cancer Xenograft Model with DNA Repair Gene Expressions].

Effect of (131)I gelatin microspheres on hepatocellular carcinoma in nude mice and its distribution after intratumoral injection.

Evaluation of Therapeutic Effectiveness Of131i-Antiegfr-bsa-pcl in a Mouse Model of Colorectal Cancer

Effect of targeting IL18-EGF fused protein on the antineoplastic activity in vivo